SARS-CoV-2 and the pancreas: What do we know about acute pancreatitis in COVID-19 positive patients?
World J Gastroenterol
; 28(36): 5240-5249, 2022 Sep 28.
Статья
в английский
| MEDLINE | ID: covidwho-2055461
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause pancreatic damage, both directly to the pancreas via angiotensin-converting enzyme 2 receptors (the transmembrane proteins required for SARS-CoV-2 entry, which are highly expressed by pancreatic cells) and indirectly through locoregional vasculitis and thrombosis. Despite that, there is no clear evidence that SARS-CoV-2 is an etiological agent of acute pancreatitis. Acute pancreatitis in coronavirus disease 2019 (COVID-19) positive patients often recognizes biliary or alcoholic etiology. The prevalence of acute pancreatitis in COVID-19 positive patients is not exactly known. However, COVID-19 positive patients with acute pancreatitis have a higher mortality and an increased risk of intensive care unit admission and necrosis compared to COVID-19 negative patients. Acute respiratory distress syndrome is the most frequent cause of death in COVID-19 positive patients and concomitant acute pancreatitis. In this article, we reported recent evidence on the correlation between COVID-19 infection and acute pancreatitis.
ключевые слова
Полный текст:
Имеется в наличии
Коллекция:
Международные базы данных
база данных:
MEDLINE
Основная тема:
Pancreatitis
/
COVID-19
Тип исследования:
Диагностическое исследование
/
Изучение этиологии
/
Наблюдательное исследование
/
Прогностическое исследование
Темы:
Длинный Ковид
Пределы темы:
Люди
Язык:
английский
Журнал:
World J Gastroenterol
Тематика журнала:
Гастроэнтерология
Год:
2022
Тип:
Статья
Аффилированная страна:
Wjg.v28.i36.5240
Документы, близкие по теме
MEDLINE
...
LILACS
LIS